ArticlePloS one2015

An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity.

Gunnstein Norheim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.